Taken together, we propose that the myocardin inhibition-insulin resistance-increased FoxO1 expression signaling axis plays a central role in promoting lipid and glucose metabolism disorder and the development of cardiomyopathy in Atp6v0d1AKO mice (Figure 7N). This evidence concerns the gene MYOCD and glucose metabolism disease.